Newsletter – Sept. 2015


Sixth Annual FOMA District 7 Seminar

Saturday, November 7, 2015
LECOM – Bradenton – Lakewood Ranch


The FOMA District 7 Goal of Student Involvement

Since we met last, our goal of involving the students of LECOM, our link to the future, has made strides. I personally attended a meeting accompanied by a 4th year LECOM Student for an open forum question answer session with the FOMA chapter. We were well received, but sadly the message was clear. They had no idea osteopaths in the community cared a bit about them. Doctors they are truly hungry for your leadership and attention. Consider teaching in your office, or spending an hour with them one evening speaking on anything you wish.


Thoughts from Nikki Wells a Second Year at LECOM

When asked for my thoughts on becoming a second year, all I can think is “wow.”  I can’t believe second year is already here.  It honestly feels like just yesterday I was going through first year orientation, meeting my Big Sibling and trying to find my place in that room of almost 200 students.  Sitting in that room during orientation, I couldn’t help but feel anxious.  I was anxious to start school, to start really working towards something I’d been seeking for a long time.  A large part of me couldn’t believe I was actually there.  A part of me still feels that way.
With second year just around the corner, I admit that I am still apprehensive because second year is a little terrifying.  Boards will happen.  I saw the second years last year consumed by board studying, but now it will be me stressing out in the library.  When they say that medical school is like drinking from a fire hydrant, they mean it.  That is one of the biggest challenges.  How do I get all this information in my head, and how do I pull it out later so I can apply it?  I’m torn between being ready to start in a few weeks and doing anything possible to make my summer last longer.  However, second year is also exciting, because after obtaining the foundation of basic sciences from my first year, I can delve deeper into the pathophysiology and the pharmacological treatment of diseases.  This will only help me prepare for boards and for my rotations in third and fourth year.  Being a second year also means being a mentor for the incoming first years, which is rewarding in itself.
I was fortunate enough to be a part of the Rural Medical Scholars Program and do a rural rotation over the summer in Port St. Joe and Apalachicola, Florida.  I was one of twelve students, and the majority of us came from LECOM.  It was a great opportunity for us to obtain clinical experience and to also expose three rural communities to osteopathic medicine.  As a representative of FOMA, I explained what osteopathic medicine is and what it isn’t whenever I was asked.  No, I’m not a chiropractor.  Yes, I will be a real doctor and can do anything an M.D. can do.  In the six weeks I was there, I had one patient who knew what a D.O. was when I introduced myself.  That was the highlight of my morning.
I joined FOMA because of the local involvement in the state that I have called home for most of my life.  Why wouldn’t I want to be part of making it a better place?  As president of the LECOM Student Chapter and with my fellow classmates,  am looking forward to being involved with our local D.O. community, building a closer relationship, and having mentors that we can pass on to future students.
I’m expecting this next year to go just as fast, if not faster, than last year.  The beginning of this year brings the stress of boards a little bit closer to the forefront of our worries, and with each day that passes, it gets closer and closer.  I think it’s important for us to remember that as daunting as our first year initially seemed, we got through it, and with that in mind, we’ll get through our second year.  Based on what the incoming first years are posting on Facebook, I can see that they’re already worried.  As rising second years, we should tell them that everything will be ok, that they will make it, and that it is possible because we did it and they can too.


Nikki Wells has been invited to attend The FOMA District 7 board meetings and has become a valued contributor to FOMA District




Presidents Message,

Dear Members, Friends, and Associates:

As we look forward to future events, The FOMA District 7 in conjunction with the Florida Osteopathic Medical Association is pleased to sponsor our Sixth Annual Seminar at LECOM – Bradenton/ Lakewood Ranch, Saturday November 7, 2015. The program will cover all of the Florida State Mandated CME’s in one day.

Offering 8 Hours AOA Category 1-A CME Credits must have credits before March 31, 2015.
We have excellent, knowledgeable speakers to cover these topics.

The registration fee for physicians will be $195.00 (lunch included). The registration fee for
PA, RN, ARNP, and Residents will be $125.00, interns & Students Free.
Seminar Registration Form on page 4

Our annual “Holiday Dinner Meeting” Will be held at Marina Jack, 2 Marina Plaza, in Sarasota on Tuesday, December 8, 2015. We will begin at 6:30 with social time followed by dinner and program. Marina Jack is one of Sarasota’s wonderful waterfront restaurants overlooking Sarasota Bay.

Send in your RSVP to
Or call 847-323-2617

We continue to strive to move our district in a positive direction. However we need your participation to support these activities. Our Dinner meetings offer a great opportunity for each of us to network with our fellow osteopathic physicians. I hope to see you at both of these events.

Tony Montanaro, DO




Lake Erie Collage of Osteopathic Medicine
Lakewood Ranch



The program will include All Florida State Mandated CME’s and noted outside guest lecturers.

Professional and Medical Ethics,
Florida Laws and Rules, Prevention of Medical Errors
Federal and State laws related to Prescribing Controlled Substances, HIV/Aids, and Domestic Violence

FOMA District 7 in conjunction with the Florida Osteopathic Medical Association is pleased to sponsor our Sixth Annual Seminar at LECOM – Lakewood Ranch. The program was carefully planned and structured by a committee of osteopathic physicians. Who have attempted to provide topics of special interest for all attendees. The CME Programs are designed to help physicians give the best care to their patients.


FOMA District 7
8:00AM – 5:30PM
Lake Erie Collage of Osteopathic Medicine – Lakewood Ranch, FL


    Florida Laws and Rules, Prevention of Medical Errors,
    Professional & Medical Ethics, HIV/AIDS, Domestic Violence
    Federal & State Laws Related to Prescribing Controlled Substances


  • RE-Licensure CME’s in one day
    Must earn credits before March 31, 2016
    Physician Registration Fee – $195.00 (Includes Lunch)
    PA, RN, ARNP, Resident Fee – $125.00 – Interns & Students Free
    Seminar Registration Form

AOA Number ______________________FL License_________________________
Phone ___________________Email (very important) _________________________

To register make checks payable to FOMA District 7 send your check and registration form to:
FOMA District 7
PO Box 21383
Sarasota, FL 34276


To register online go to  Events

Questions Email or call Linda at 847-323-2617


Update on the Single Accreditation System

As of July 2015 all current Osteopathic accredited graduate medical education program are eligible for pre-accreditation by the Accreditation Council on Graduate Medical Education (ACGME).  After a program receives pre-accreditation status it will be eligible at, no additional cost to apply for Osteopathic Recognition (OR).  OR will be granted by the Osteopathic Principles Committee (OPC) once it is determined the program meets the requirement for this designation. OR programs will be parallel to current AOA accredited programs.  It is important to remember as of 2020 the AOA will no longer accredit any graduate medical education (GME) programs, therefore, all programs that wish to continue GME must enter this process. This movement to the Single Accreditation System (SAS) was agreed to by the AOA and the ACGME as outlined in their Memorandum of Understanding signed in 2014.

It is now very important to assure the 134 years of Osteopathic Medicines’ contribution to patient care and American Medicine is preserved and continued. To this end the AOA and ACGME have been very timely and diligent in providing a smooth transition to the SAS while preserving the unique contribution of osteopathic medicine.

The ACGME has named Lorenzo Pence, DO, FACOFP, as its new Senior Vice President to oversee osteopathic program accreditation. Dr. Pence will ensure osteopathic medical standards are upheld as the ACGME begins accepting osteopathic residency programs into its system.  Two key committees composed of primarily AOA boarded physicians with representation by ABMS boarded physicians were appointed and have completed their charge to preserve osteopathic medicine in the new system.  The Osteopathic Principles Committee and the Osteopathic Neuromuscular Medicine Review Committee have completed their respective program requirement and the requirements have been approved by the ACGME Board of Directors.  This approval “codifies” osteopathic medicine’s 134 year contributions to patient care and the American health system in the ACGME SAS.  To quote the AOA “this historic development in medical education in the U.S., for the first time osteopathic principles and practices (OPP) are incorporated into the ACGME accreditation system”.

Probably one of the most difficult issues was the possibility AOA boarded physicians would not be eligible to serve as program directors in the ACGME SAS. However, the latest information from the AOA and the ACGME is the announcement of acceptance of AOA boarded physicians as eligible for serving as program directors in the ACGME.  Early on in the formation of the SAS, it was expected that a DO not boarded by American Board of Medical Specialist (ABMS) could serve as faculty in an ACGME program as they do now but not as program directors in an ACGME program. However, one by one the ACGME Review Committees have approved acceptance of AOA boarded DOs for program director eligibility in the ACGME.

As of this date, 18 ACGME Review Committees (RCs) have announced they will accept AOA certification as a qualification for program directors of osteopathic programs and not require an ABMS-certified co-program director.

This represents about 87% of AOA-certified programs.  The Review Committees accepting AOA boarded physicians as program directors are: Allergy and Immunology, Anesthesiology, Ophthalmology, Pediatrics, Plastic Surgery, Psychiatry, Orthopedic Surgery, Emergency Medicine, Obstetrics and Gynecology, Pathology, Physical Medicine and Rehabilitation, Preventive Medicine, Dermatology, Diagnostic Radiology, Family Medicine, Internal Medicine, Surgery and Neurology.


The Single accreditation System, Continued…

Three RCs – urology, otolaryngology and neurosurgery –currently require co-directors, accounting for about 40 of AOA’s 1,205 programs.  It is important to keep in mind all program directors, whether AOA boarded or ABMS boarded, must meet the other eligibility requirements to be approved.

To date the transition is further along in terms of integration of AOA GME into the ACGME than many anticipated. The next step is the transition of all AOA programs through the formal application process into the ACGME. A current AOA accredited program will be considered as pre-accredited by the ACGME upon an application being submitted. The ACGME will then assist the program in further developing the application as needed.  The ACGME considers AOA program requirements to be in “80%” compliance with the ACGME requirements. Substantial compliance is the standard that is applied to all the ACGME programs for accreditation and it is anticipated AOA programs will meet these requirements.

For those who are interested in the future of osteopathic  GME I encourage you to visit the ACGME Web Site periodically to review the latest updates, Webinars and follow the news of AOA program accreditation in the SAS.

Anthony N. Ottaviani, DO, MPH MACOI, FCCP
Member Osteopathic Principles Committee
Accreditation Council for Graduate Medical Education
Chief Academic Officer
Regional Dean
Nova Southeastern University
Largo Medical Center



Effective June 13, 2015 Physicians who do not receive Medicare payments, but who privately contract with Medicare patients, will not have to renew those agreements. Instead, such private agreements between physicians and patients will be automatically extended. Under the newly passed Medicare Access and CHIP Reauthorization Act (MACRA), private contracts between physicians and part B beneficiaries will be automatically extended unless the physician provides a notice of non-extension not later than 30 days before the end of the contract period.
The policy is effective for new affidavits signed on or after June 13, 2015. Current contracts up for renewal on or after June 13 are also included under this policy. Participating physicians may opt – out of Medicare at the beginning of any calendar, quarter, provided that the affidavit is submitted to the participating physicians Medicare contractor at least 30 days before the beginning of the selected calendar quarter.
The centers for Medicare and Medicaid Services (CMS) will also make certain information on providers in private contracts publicly available by February 1, 2016, including specialty or other designation and geographic distribution. This information will be updated annually. To learn more about opting out of Medicare, CMS has further information online. In addition, Medicare Administrative contractors will be able to answer questions.
Orkideh Malkoc, Director, Policy Engagement,




PURDUE PHARMA Announces Team Against Opioid Abuse

Purdue Pharma is proud to introduce Team Against Opioid Abuse, a new website designed to help healthcare professionals and laypeople alike learn about different abuse-deterrent technologies and how they can help in the reduction of misuse and abuse of opioids. Combating misuse and intentional abuse of prescription pain relievers involves more than just the person holding the prescription pad. It is a team effort, including pharmacists, nurses, counselors, caregivers, patients, and payers, both public- and private-sector. Public health experts have stated that Opioids with Abuse-Deterrent Properties (OADP) are an essential component of a comprehensive, evidence-based strategy to reduce opioid abuse that requires coordinated and sustained efforts from the healthcare team along with multiple other players, such as manufacturers, policymakers, regulators, educators, and law enforcement.
“Education about the proper use of opioid analgesics is a top priority at Purdue Pharma. Everyone on the team should understand their role and responsibilities, so they can do their part in combating abuse of opioids, while ensuring their availability for appropriate purposes,” said J. David Haddox, DDS, MD, Vice President, Health Policy, Purdue Pharma L.P. “Opioids with Abuse-Deterrent Properties are one tool to help the team in their efforts in fighting drug abuse. We developed this website to inform everyone who influences how drugs are prescribed, taken, stored, and destroyed, when no longer needed.”
Opioid abuse is a critical problem in America and one that healthcare professionals, payers, law enforcement, policymakers and drug makers are all working to combat. The 2013 National Survey on Drug Use and Health reported that, among persons age 12 or older in 2012 to 2013, approximately 68 percent of people who used prescription pain relievers for nonmedical purposes said they got the medicines from a friend or relative, for free, by purchase, or by theft.[1] In 2011, the White House identified prescription drug abuse and misuse as a major public health and public safety crisis.[2]
Using clear graphics and easy to understand language, the website features sections about why it’s critical to deter abuse and how all the members on the healthcare team can make a difference. It also outlines the 2015 Food & Drug Administration’s Guidance on Abuse-Deterrent Opioids – Evaluation and Labeling, which informs drug developers about FDA’s current thinking on what kinds of testing potentially abuse-deterrent opioids should undergo. Because FDA states that having information about an opioid’s abuse deterrence available for healthcare professionals and patients, the website also reviews how Section 9.2 of a drug product’s Full Prescribing Information is the key to identifying opioid formulations with FDA-approved abuse-deterrent properties.[3]
The Team Against Opioid Abuse website can be can be accessed at